{"chunk_type":"transcript_chunk","text":"# nephro ì¦‰ë°˜\n# ğŸ“– USMLE Nephrology: The \"Grand Bible\" (Final Version)\n## ğŸ¯ Part 1. Electrolytes (ì „í•´ì§ˆ) - \"ì£½ëŠëƒ ì‚¬ëŠëƒ\"\n### 1. Hyponatremia (Low Na)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì†Œê¸ˆì´ ë¶€ì¡±í•œ ê²Œ ì•„ëƒ! ë¬¼ì´ ë„ˆë¬´ ë§ì€ ê±°ì•¼(Dilution).\"**\n- **[Lab: Low Na + Urine Osmolality > 100 (High)]** -> **[Think: SIADH]**\n    - **SIADH**ëŠ” ADH(í•­ì´ë‡¨í˜¸ë¥´ëª¬)ê°€ ë¯¸ì³ ë‚ ë›°ì–´ì„œ ë¬¼ì„ ëª» ì‹¸ê²Œ ë§‰ëŠ” ë³‘ì´ì•¼. ëª¸ì´ ë¬¼í’ì„ ì´ ë¼.\n    - *ì›ì¸*: **Small Cell Lung Cancer** (íì•” í™˜ìê°€ Na ë–¨ì–´ì§€ë©´ 100%), ë‡Œì§ˆí™˜, ì•½ë¬¼(SSRI, Carbamazepine).\n    - *ì¹˜ë£Œ*: **Fluid Restriction** (ë¬¼ ëª» ë§ˆì‹œê²Œ í•´). ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **Demeclocycline** (ADH ì°¨ë‹¨).\n- **[Lab: Low Na + Urine Osmolality < 100 (Dilute)]** -> **[Think: Polydipsia]**\n    - ì´ê±´ ì‹ ì¥ì€ ì •ìƒì´ì•¼. í™˜ìê°€ ì •ì‹ ê³¼ ë¬¸ì œë¡œ ë¬¼ì„ í•˜ë£¨ì— 10Lì”© ë§ˆì…”ëŒ„ ê±°ì•¼(Psychogenic). ADHëŠ” êº¼ì ¸ìˆìŒ.\n- **[Tx Condition: Na < 120 or Seizure]** -> **[Warning: Correct Slowly!]**\n    - **ì ˆëŒ€ ê·œì¹™**: í•˜ë£¨ì— **8-10 mEq/L** ì´ìƒ ì˜¬ë¦¬ì§€ ë§ˆë¼.\n    - ë¹¨ë¦¬ ì˜¬ë¦¬ë©´? -> ë‡Œì„¸í¬ ìˆ˜ë¶„ì´ í™• ë¹ ì§€ë©´ì„œ **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** ì˜¨ë‹¤. (Locked-in syndrome: ëˆˆë§Œ ê¹œë¹¡ì´ê³  ì „ì‹  ë§ˆë¹„).\n### 2. Hypernatremia (High Na)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë¬¼ì„ ëª» ë§ˆì‹œê±°ë‚˜, ë§¹ë¬¼ë§Œ ì¤„ì¤„ ì‹¸ëŠ” ë³‘(DI)ì´ë‹¤.\"**\n- **[Sx: Polyuria + High Na]** -> **[Think: Diabetes Insipidus (DI)]**\n    - ë‹¹ë‡¨(DM)ë‘ ìƒê´€ì—†ì–´. ADHê°€ ì—†ê±°ë‚˜(Central), ì•ˆ ë“£ëŠ” ê±°ì•¼(Nephrogenic).\n- **[Test: Water Deprivation Test]** -> **[Analysis]**\n    - ë¬¼ì„ ëŠì—ˆëŠ”ë°ë„ ì˜¤ì¤Œ ë†ì¶•ì´ ì•ˆ ëœë‹¤? -> **DI í™•ì •**.\n    - ê·¸ë‹¤ìŒ **Desmopressin (ADH)**ì„ ì¤˜ë´.\n        - ì˜¤ì¤Œì´ ë†ì¶•ëœë‹¤(Osm ì¦ê°€)? -> ë‡Œê°€ ë¬¸ì œë‹¤ (**Central DI**).\n        - ë°˜ì‘ ì—†ë‹¤? -> ì‹ ì¥ì´ ë§›ê°”ë‹¤ (**Nephrogenic DI**).\n- **[Drug SE: Bipolar Pt on Lithium -> Polyuria]** -> **[Think: Nephrogenic DI]**\n    - **ë¦¬íŠ¬(Lithium)** ë¨¹ëŠ” í™˜ìê°€ ì˜¤ì¤Œ ìì£¼ ì‹¸ë©´ ë¬´ì¡°ê±´ ì´ê±°ì•¼.\n    - *ì¹˜ë£Œ*: ì—­ì„¤ì ì´ì§€ë§Œ **HCTZ (Thiazide)**ë‚˜ **Amiloride**ë¥¼ ì“´ë‹¤.\n\n    ### ğŸ§  Mental Framework\n\n    \"Na ë¬¸ì œëŠ” **'ì†Œê¸ˆ í†µ'** ë¬¸ì œê°€ ì•„ë‹ˆë¼ **'ë¬¼ í†µ'** ë¬¸ì œì•¼. ADH í˜¸ë¥´ëª¬ì´ ìŠ¤ìœ„ì¹˜ë¥¼ ì¼°ëƒ(SIADH), ê»ëƒ(DI) ì‹¸ì›€ì´ë‹¤.\"\n### 3. Hyperkalemia (High K)\n- ğŸ—£ï¸ **Golden Voice**: **\"K ìˆ˜ì¹˜ ë†’ìœ¼ë©´ ìˆ«ì ë³´ì§€ ë§ê³  'ì‹¬ì „ë„(ECG)'ë¶€í„° ë´!\"**\n- âš¡ **Exam Reflex**:\n    - **ECG**: **Peaked T waves** -> Wide QRS -> Sine wave -> ì‚¬ë§.\n    - **ì¹˜ë£Œ ìˆœì„œ (C-I-K)**:\n        1. **C**alcium Gluconate (ì‹¬ì¥ë§‰ ì•ˆì • - **ê°€ì¥ ë¨¼ì €!**)\n        2. **I**nsulin (+Glucose) (ì„¸í¬ ë‚´ë¡œ ì´ë™)\n        3. **K**ayexalate / Diuretics (ëª¸ ë°–ìœ¼ë¡œ ë°°ì¶œ)\n### 4. Hypokalemia (Low K)\n- ğŸ—£ï¸ **Golden Voice**: **\"Kê°€ ë‚®ìœ¼ë©´ í˜ë¹ ì§€ê³  ë¶€ì •ë§¥ì˜¤ê³  'Digoxin'ì´ ë…ì•½ìœ¼ë¡œ ë³€í•˜ê³ , 'Mg'ê°€ ë²”ì¸ì¼ ìˆ˜ ìˆë‹¤.\"**\n- **[ECG: U waves + Flattened T]** -> **[Think: Hypokalemia]**\n    - TíŒŒê°€ ë‚©ì‘í•´ì§€ê³  ê·¸ ë’¤ì— **U wave**ë¼ëŠ” í˜¹ì´ í•˜ë‚˜ ë” ìƒê²¨.\n- **[Condition: Digoxin user]** -> **[Warning: Toxicity Risk!]**\n    - Kê°€ ë‚®ìœ¼ë©´ **Digoxin**ì´ ì‹¬ì¥ì— ë” ë‹¬ë¼ë¶™ì–´. **Digoxin Toxicity** í„°ì§„ë‹¤.\n    - *ì¦ìƒ*: ë…¸ë€ìƒ‰ ì„¸ìƒ(Yellow vision), êµ¬í† , ë¶€ì •ë§¥.\n- **[Case: Replenishing K but not correcting?]** -> **[Check: Magnesium!]**\n    - Kë¥¼ ì•„ë¬´ë¦¬ ì¤˜ë„ ìˆ˜ì¹˜ê°€ ì•ˆ ì˜¤ë¥¸ë‹¤? ë²”ì¸ì€ **Hypomagnesemia**ì•¼.\n    - Mgê°€ ì—†ìœ¼ë©´ ì‹ ì¥ì´ Kë¥¼ ëª» ì¡ì•„ë‘ê³  ë‹¤ ë²„ë ¤. **Mg ë¨¼ì € êµì •í•´!**\n### 5. Calcium (Ca)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì¹¼ìŠ˜ì´ ë†’ìœ¼ë©´ 'ì•” vs ë¶€ê°‘ìƒì„ ', ë‚®ìœ¼ë©´ 'ìˆ˜ìˆ  í›„ ë–¨ë¦¼'ì´ë‹¤.\"**\n### âš¡ EXAM REFLEX: Hypercalcemia (High Ca)\n**\"ì¹¼ìŠ˜ì´ ë†’ìœ¼ë©´ ëŒ ìƒê¸°ê³ , ë¼ˆ ì‚­ê³ , ë³€ë¹„ ìƒê¸°ê³ , ì •ì‹  ë‚˜ê°„ë‹¤.\"**\nâ€œì•” vs hyper PTH (ì‚¬ê³¨ê°€ê²Œ)â€\n1. **[Sx: Stones, Bones, Groans, Moans]** -> **[Think: Hyperparathyroidism or Cancer]**\n    - ì¦ìƒì´ ë„ˆë¬´ ë‹¤ì–‘í•´(ì‹ ì¥ê²°ì„, ë¼ˆ í†µì¦, ë³€ë¹„/ë³µí†µ, ìš°ìš¸ì¦). ì´ê±¸ë¡œ í‰ì³ì„œ ì™¸ì›Œ.\n2. **[Lab: High Ca + High PTH]** -> **[Think: Primary Hyperparathyroidism]**\n    - ë¶€ê°‘ìƒì„ ì— í˜¹(Adenoma)ì´ ìƒê²¨ì„œ PTHë¥¼ ë¯¸ì¹œ ë“¯ì´ ë¿œì–´ë‚´ëŠ” ê±°ì•¼.\n    - *Reflex*: ìˆ˜ìˆ ë¡œ ë–¼ë‚´ëŠ” ê²Œ ë‹µì´ë‹¤.\n3. **[Lab: High Ca + Low PTH]** -> **[Think: Malignancy (Cancer)]**\n    - ì•”ì„¸í¬ê°€ ë¼ˆë¥¼ ë…¹ì´ê±°ë‚˜(Metastasis), PTHë‘ ë¹„ìŠ·í•˜ê²Œ ìƒê¸´ ë†ˆ(**PTHrP**)ì„ ë§Œë“œëŠ” ê±°ì•¼ (Lung Squamous Cell Ca).\n    - *Reflex*: ë¬´ì¡°ê±´ **ìˆ˜ì•¡(Saline)**ë¶€í„° ì½¸ì½¸ ë¶“ê³ , **Bisphosphonate** ì¤€ë¹„í•´.\n### âš¡ EXAM REFLEX: Hypocalcemia (Low Ca)\n**\"ì¹¼ìŠ˜ì´ ì—†ìœ¼ë©´ ì‹ ê²½ì´ ì˜ˆë¯¼í•´ì ¸ì„œ ë°”ë“¤ë°”ë“¤ ë–¨ë ¤.\"**\nâ€œìˆ˜ìˆ ë ¥ í™•ì¸â€","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-1","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"1. **[PE: Chvostek / Trousseau Sign]** -> **[Think: Hypocalcemia]**\n    - ë³¼ í†¡ ì¹˜ë©´ ì…ìˆ  ì”°ë£©(Chvostek), í˜ˆì••ê³„ ê°ìœ¼ë©´ ì†ëª© êº¾ì„(Trousseau). ì´ê±° ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ ì €ì¹¼ìŠ˜ì´ì•¼.\n2. **[Hx: Thyroid Surgery]** -> **[Suspect: Parathyroid Damage]**\n    - ê°‘ìƒì„  ìˆ˜ìˆ í•˜ë‹¤ê°€ ë¶€ê°‘ìƒì„ ê¹Œì§€ ê°™ì´ ë‚ ë ¤ë¨¹ì€ ì¼€ì´ìŠ¤ê°€ ì œì¼ í”í•´.\n3. **[ECG: QT Prolongation]** -> **[Warning: Arrhythmia]**\n    - QT ê°„ê²©ì´ ëŠ˜ì–´ì ¸. ì¬ìˆ˜ ì—†ìœ¼ë©´ Torsades de pointes í„°ì§„ë‹¤\n\n    ## 2. ğŸ›¡ï¸ Magnesium (Mg) Imbalance\n\n    ### ğŸ—ºï¸ Context Navigation\n\n    Electrolyte_Imbalances\n    â”œâ”€â”€ Magnesium\n    â”‚   â””â”€â”€ Hypomagnesemia (The Troublemaker)\n\n    ### âš¡ EXAM REFLEX\n\n    **\"ë§ˆê·¸ë„¤ìŠ˜ì€ í˜¼ì ì•ˆ ë‹¤ë…€. ì¹¼ìŠ˜ì´ë‘ ì¹¼ë¥¨ì„ ë¬¼ê·€ì‹ ì²˜ëŸ¼ ëŒê³  ë‹¤ë…€.\"**\n\n    1. **[Lab: Low K + Low Ca (Refractory)]** -> **[Check: Magnesium]**\n        - ì¹¼ë¥¨(K)ë‘ ì¹¼ìŠ˜(Ca)ì„ ì•„ë¬´ë¦¬ ì¤˜ë„ ìˆ˜ì¹˜ê°€ ì•ˆ ì˜¬ë¼? ë²”ì¸ì€ 100% **ì €ë§ˆê·¸ë„¤ìŠ˜(Hypomagnesemia)**ì´ì•¼.\n        - Mgê°€ ì—†ìœ¼ë©´ KëŠ” ì†Œë³€ìœ¼ë¡œ ìƒˆê³ , PTHê°€ ì‘ë™ ì•ˆ í•´ì„œ Caë„ ì•ˆ ì˜¬ë¼ê°€. **Mg ë¨¼ì € êµì •í•´!**\n    2. **[ECG: Torsades de Pointes]** -> **[Tx: Magnesium Sulfate]**\n        - ìˆ ê³ ë˜(Alcoholic)ê°€ ì“°ëŸ¬ì ¸ì„œ ì‹¬ì „ë„ ê¼¬ì˜€ì–´?\n        - ë¬´ì¡°ê±´ **ë§ˆê·¸ë„¤ìŠ˜ ì„¤í˜ì´íŠ¸(Mg-Sulfate)** ì´ë¼. ì´ê²Œ íŠ¹íš¨ì•½ì´ë‹¤.\n\n    ### ğŸ§  Mental Framework\n\n    \"**'êµì •ì´ ì•ˆ ë˜ëŠ” ì „í•´ì§ˆ ë¶ˆê· í˜•'**ì´ë‚˜ **'ì•Œì½œ ì¤‘ë…ì'** ë‚˜ì˜¤ë©´ ìˆ¨ê²¨ì§„ ë²”ì¸ **Mg**ë¥¼ ì°¾ì•„ë‚´.\"\n---\n## ğŸ¯ Part 2. Acid-Base (ì‚°ì—¼ê¸°) - \"ê³„ì‚°ê¸° ì‹¸ì›€\"\n### 1. Metabolic Acidosis (Low pH, Low HCO3)\n- ğŸ—£ï¸ **Golden Voice**: **\"pH ë‚®ìœ¼ë©´ ë¬´ì¡°ê±´ 'Anion Gap'ë¶€í„° ê³„ì‚°í•´.\"**\n- âš¡ **Exam Reflex**:\n    - **ê³µì‹**: Gap = **Na - (Cl + HCO3)** (ì •ìƒ 8~12).\n    - **High Gap (>12)**: **MUDPILES** (Methanol, Uremia, DKA, Iron, Lactic, Ethylene glycol, Salicylates).\n    - **Normal Gap**: ì„¤ì‚¬(Diarrhea) ì•„ë‹ˆë©´ **RTA**.\n### 2. Renal Tubular Acidosis (RTA) - Normal Gap\n- ğŸ—£ï¸ **Golden Voice**: **\"ì†Œë³€ pH, ê²°ì„, ì¹¼ë¥¨ ìˆ˜ì¹˜ë¡œ 1, 2, 4í˜•ì„ ê°€ë¥¸ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Type 1 (Distal)**: ì†Œë³€ pH > 5.5 + **ì‹ ì¥ ê²°ì„(Stones)**.\n    - **Type 2 (Proximal)**: **Fanconi Syndrome** + Multiple Myeloma.\n    - **Type 4**: ìœ ì¼í•˜ê²Œ **Hyperkalemia (ê³ ì¹¼ë¥¨)** + ë‹¹ë‡¨ë³‘(Diabetes).\n### 3. Metabolic Alkalosis (High pH, High HCO3)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì•Œì¹¼ë¦¬ì¦ì€ 'ì†Œë³€ ì—¼ì†Œ(Urine Cl)'ë¡œ ë²”ì¸ì„ ê°€ë¥¸ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Urine Cl < 10 (Low)**: êµ¬í† (Vomiting), ì´ë‡¨ì œ ì‚¬ìš©. -> **Saline(ìˆ˜ì•¡)** ì£¼ë©´ ì¹˜ë£Œë¨.\n    - **Urine Cl > 20 (High)**: ì•Œë„ìŠ¤í…Œë¡  ê³¼ë‹¤(Conn, Cushing). -> ìˆ˜ì•¡ ì¤˜ë„ ì•ˆ ë¨.\n<aside>\nğŸ’¡\n### ğŸ§  Mental Framework\n\"ì‚°ì—¼ê¸°ëŠ” **Gap ê³„ì‚°**ì´ 1ë²ˆ, **ì†Œë³€ Cl** í™•ì¸ì´ 2ë²ˆì´ì•¼. **RTA**ëŠ” ìˆ«ì(1,2,4)ë‘ íŠ¹ì§•(ëŒ, ë§ˆì´ì—˜ë¡œë§ˆ, ê³ ì¹¼ë¥¨) ë§¤ì¹­í•´.\"\n</aside>\n---\n## ğŸ¯ Part 3. AKI & Failure (ì‹ ë¶€ì „) - \"ì›ì¸ ì°¾ê¸°\"\n### 1. Prerenal vs Intrinsic (ATN)\n- ğŸ—£ï¸ **Golden Voice**: **\"BUN/Cr 20 ë„˜ìœ¼ë©´ 'ëª©ë§ˆë¥¸ ë†ˆ', ì•ˆ ë„˜ìœ¼ë©´ 'ê³ ì¥ ë‚œ ë†ˆ'ì´ë‹¤.\" â€œëª©ë§ˆë¥´ë©´ ì•ˆë²„ë¦°ë‹¤â€**\n- âš¡ **Exam Reflex**:\n    - **Prerenal**: íƒˆìˆ˜. ì‹ ì¥ì´ ì†Œë³€ ë†ì¶•í•¨ (**FeNa < 1%**). -> ì¹˜ë£Œ: **ìˆ˜ì•¡**.\n    - **Intrinsic (ATN)**: íŠœë¸Œ ê´´ì‚¬. ë†ì¶• ëª» í•¨ (**FeNa > 2%**). -> íŠ¹ì§•: **Muddy Brown Casts**.\n### 2. Rhabdomyolysis (íš¡ë¬¸ê·¼ìœµí•´ì¦)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë”¥ìŠ¤í‹±ì€ í”¼(Blood)ë¼ëŠ”ë° í˜„ë¯¸ê²½ì—” ì í˜ˆêµ¬(RBC)ê°€ ì—†ë‹¤? 100% ëë„ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **ì›ì¸**: ê·¼ìœ¡ ì†ìƒ(Crush, Seizure, Statin).\n    - **ë¬¼ì§ˆ**: Myoglobin (ì‹ ì¥ ë…ì„±).\n    - **ì¹˜ë£Œ**: ì‹ ì¥ ë§ê°€ì§€ê¸° ì „ì— **ìˆ˜ì•¡(Hydration)** ì½¸ì½¸ ë¶€ì–´ë¼.\n### 3. Acute Interstitial Nephritis (AIN)","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-21","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"- ğŸ—£ï¸ **Golden Voice**: **\"ìƒˆ ì•½ ë¨¹ê³  ì—´ë‚˜ê³  ë°œì§„ ìƒê¸°ë©´, ì‹ ì¥ì— ë‘ë“œëŸ¬ê¸°(ì•Œë ˆë¥´ê¸°) ë‚œ ê±°ë‹¤.\"**\n### âš¡ EXAM REFLEX\n**\"ìƒˆ ì•½ ë¨¹ê³ , ì—´ë‚˜ê³ , í”¼ë¶€ ë°œì§„ ìƒê¸°ê³ , ì˜¤ì¤Œì— í˜¸ì‚°êµ¬(Eosinophil) ë–´ë‹¤?\"**\n1. **[Hx: New Drug (NSAIDs, Penicillin, PPI, Diuretics)]** -> **[Think: AIN]**\n    - í™˜ìê°€ ìµœê·¼ì— ê°ê¸°ì•½(NSAID)ì´ë‚˜ ì†ì“°ë¦¼ ì•½(PPI) ë¨¹ê¸° ì‹œì‘í–ˆì–´.\n    - ê°‘ìê¸° **ì—´(Fever)** ë‚˜ê³  **í”¼ë¶€ ë°œì§„(Rash)** ìƒê²¨.\n2. **[UA: WBC Casts + Eosinophils]** -> **[Confirm: AIN]**\n    - ì†Œë³€ì— **ë°±í˜ˆêµ¬(WBC)**ê°€ ë³´ì´ëŠ”ë° ê°ì—¼(UTI)ì€ ì•„ë‹ˆì•¼(ê· ì´ ì•ˆ ìë¼).\n    - Hansel stainì´ë‚˜ Wright stainìœ¼ë¡œ **í˜¸ì‚°êµ¬(Eosinophil)** ë³´ì´ë©´ 100%ë‹¤.\n    - *Reflex*: **ì•½ ëŠì–´(Stop the drug)!** ê·¸ê²Œ ì¹˜ë£Œì•¼. ìŠ¤í…Œë¡œì´ë“œëŠ” ê·¸ ë‹¤ìŒ.\n### ğŸ§  Mental Framework\n\"**AIN**ì€ ì‹ ì¥ì— ìƒê¸´ **ë‘ë“œëŸ¬ê¸°(Allergy)**ì•¼. ë²”ì¸(ì•½)ë§Œ ì¡ìœ¼ë©´ í•´ê²°ë¼.\"\n### Renal osteodystrophy\n### âš¡ EXAM REFLEX\n**\"ì¸ì€ ì•ˆ ë‚˜ê°€ê³ , ë¹„íƒ€ë¯¼ DëŠ” ì•ˆ ë§Œë“¤ì–´ì ¸. ê²°êµ­ ë¼ˆë¥¼ ë…¹ì—¬ì„œ ì¹¼ìŠ˜ì„ ë½‘ì•„ ì“´ë‹¤.\"**\n1. **[Lab: High Phosphate (PO4)]** -> **[Mechanism Start]**\n    - ì‹ ì¥ì´ ë§›ê°€ì„œ **ì¸(PO4)** ë°°ì¶œì„ ëª» í•´. ëª¸ì— ì¸ì´ ìŒ“ì—¬.\n    - ì¸ì€ ì¹¼ìŠ˜ì´ë‘ ìì„ì²˜ëŸ¼ ë¶™ì–´(**Ca-PO4 ê²°í•©**). -> í˜ˆì¤‘ **ì¹¼ìŠ˜(Free Ca)ì´ ëš ë–¨ì–´ì§**.\n2. **[Lab: Low Vit D (Calcitriol)]** -> **[Worsening Low Ca]**\n    - ì‹ ì¥ì˜ ì¤‘ìš”í•œ ì—­í• ì´ ë¹„íƒ€ë¯¼ D í™œì„±í™”(1-alpha hydroxylation)ì•¼. ì´ê±¸ ëª» í•˜ë‹ˆê¹Œ ì¥ì—ì„œ ì¹¼ìŠ˜ í¡ìˆ˜ë¥¼ ëª» í•´.\n3. **[Result: High PTH (Secondary Hyperparathyroidism)]** -> **[Bone Loss]**\n    - ì¹¼ìŠ˜ ë‚®ìœ¼ë‹ˆê¹Œ **ë¶€ê°‘ìƒì„ (Parathyroid)**ì´ ë¯¸ì³ ë‚ ë›°ì–´. \"ë¼ˆì—ì„œ ì¹¼ìŠ˜ ë¹¼ì™€!!\"\n    - ê²°ê³¼: **Osteitis Fibrosa Cystica** (ë¼ˆê°€ ë…¹ê³  êµ¬ë©ì´ ìˆ­ìˆ­ ëš«ë¦¼).\n    - *ì¹˜ë£Œ*: **Phosphate binder** (ì¸ ë¬¶ì–´ì£¼ëŠ” ì•½) ì£¼ê³  **Vit D** ë„£ì–´ì¤˜.\n### ğŸ§  Mental Framework\n\"**ì‹ ì¥ ë§ê°€ì§ -> ì¸(PO4) ìƒìŠ¹ -> ì¹¼ìŠ˜(Ca) í•˜ë½ -> PTH í­ì£¼ -> ë¼ˆ ìš©í•´.**\nì´ ì•…ìˆœí™˜ ê³ ë¦¬(Chain Reaction)ë¥¼ ìˆœì„œëŒ€ë¡œ ê·¸ë¦´ ì¤„ ì•Œì•„ì•¼ í•´.\"\n## 3. ğŸ©¸ Uremia Complications - \"The Toxins\"\n*ìš”ë…(Urea)ì´ ìŒ“ì´ë©´ ì˜¨ëª¸ì„ ê³µê²©í•´.*\n### âš¡ EXAM REFLEX\n**\"ì‹ ì¥ í™˜ìê°€ í”¼ê°€ ì•ˆ ë©ˆì¶”ê±°ë‚˜, ê°€ìŠ´ì´ ì•„í”„ë‹¤?\"**\n1. **[Sx: Bleeding (Nosebleed, Bruising)]** -> **[Lab: Normal PT/PTT, High Bleeding Time]**\n    - ì´ê²Œ í•µì‹¬ì´ì•¼! í˜ˆì•¡ì‘ê³ ì¸ì(Factor)ëŠ” ë©€ì©¡í•´ì„œ **PT/PTTëŠ” ì •ìƒ**ì´ì•¼.\n    - ìš”ë…(Uremia)ì´ **í˜ˆì†ŒíŒ(Platelet) ê¸°ëŠ¥**ì„ ë§ˆë¹„ì‹œí‚¤ëŠ” ê±°ì•¼. (Qualitative defect).\n    - *Reflex*: **Desmopressin** (vWF ë°©ì¶œ) ì“°ê±°ë‚˜ íˆ¬ì„í•´.\n2. **[Sx: Chest Pain + Friction Rub]** -> **[Think: Uremic Pericarditis]**\n    - ìš”ë…ì´ ì‹¬ì¥ë§‰(Pericardium)ì„ ê¸ì–´. ìˆ¨ ë“¤ì´ë§ˆì‹¤ ë•Œ ë” ì•„íŒŒ.\n    - ì‹¬ì „ë„(ECG)ì— **Diffuse ST elevation** ë³´ì¼ ìˆ˜ ìˆì–´.\n    - *Reflex*: ì´ê±´ **ì‘ê¸‰ íˆ¬ì„(Dialysis)** ì ì‘ì¦ì´ì•¼. ì•½ìœ¼ë¡œ ì•ˆ ë¼.\n### 4. CKD Complications (ë§Œì„± í•©ë³‘ì¦)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì‹ ì¥ì´ ë§ê°€ì§€ë©´ ì¸(PO4)ì„ ëª» ë²„ë ¤ì„œ ë¼ˆê°€ ë…¹ê³ , ìš”ë…ì´ ìŒ“ì—¬ì„œ í”¼ê°€ ì•ˆ ë©ˆì¶˜ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Renal Osteodystrophy**: ì¸ ìƒìŠ¹ -> Ca í•˜ë½ -> **PTH í­ì£¼** -> ë¼ˆ í¡ìˆ˜. (Tx: Phosphate Binder).\n    - **Uremic Bleeding**: í˜ˆì†ŒíŒ **ê¸°ëŠ¥** ì¥ì•  (ìˆ˜ì¹˜ëŠ” ì •ìƒ). **Bleeding Time**ë§Œ ì—°ì¥. (Tx: Desmopressin).\n    - **Calciphylaxis**: í”¼ë¶€ ê´´ì‚¬(Necrosis) + í†µì¦\n### 5. Dialysis (íˆ¬ì„ ì ì‘ì¦)","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-41","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- ğŸ—£ï¸ **Golden Voice**: **\"ì•½ìœ¼ë¡œ ì•ˆ ë˜ë©´ ê¸°ê³„ ëŒë ¤. 'AEIOU' ìƒí™©ì´ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **A**cidosis, **E**lectrolytes (Hyper-K), **I**ntoxication, **O**verload (Lung edema), **U**remia (Pericarditis).\n---\n## ğŸ¯ Part 4. Glomerular (ì‚¬êµ¬ì²´ì‹ ì—¼) - \"í”¼ vs ë‹¨ë°±ì§ˆ\"\n### 1. Nephritic Syndrome (Blood - Inflammation)\n- ğŸ—£ï¸ **Golden Voice**: **\"RBC Casts ë³´ì´ë©´ 'ì—¼ì¦'ì´ ë‚˜ì„œ í•„í„°ê°€ ì°¢ì–´ì§„ ê±°ë‹¤.\"**\n### âš¡ EXAM REFLEX: The \"Blood\" Trigger\n**\"í˜ˆë‡¨(Hematuria) + ê³ í˜ˆì••(HTN) + ë¶“ê¸°(Edema) + RBC Casts = Nephritic\"**\n1. **[Hx: Sore Throat -> Hematuria]** -> **[Check: Timing (Latent Period)]**\n    - **1~3ì¼ ë’¤ (Synpharyngitic)**: ê°ê¸° ê±¸ë¦¬ìë§ˆì í”¼ì˜¤ì¤Œ? -> **IgA Nephropathy**.\n        - C3 ìˆ˜ì¹˜ ì •ìƒ. ë°˜ë³µì ìœ¼ë¡œ ì¬ë°œí•¨.\n    - **2~3ì£¼ ë’¤ (Post-infectious)**: ê°ê¸° ë‹¤ ë‚«ê³  ë‚˜ì„œ í”¼ì˜¤ì¤Œ? -> **PSGN**.\n        - **C3 ê°ì†Œ(Low)**. ì–¼êµ´(Periorbital) ë¶“ê¸°.\n        - *Biopsy*: **\"Subepithelial Humps\"** (ë‚™íƒ€ ë“±ì²˜ëŸ¼ íŠ€ì–´ë‚˜ì˜´).\n2. **[Sx: Hemoptysis (Coughing Blood) + Hematuria]** -> **[Think: Lung + Kidney]**\n    - **Linear IF (Anti-GBM)** -> **Goodpasture Syndrome**. (ì Šì€ ë‚¨ì, íì¶œí˜ˆ).\n    - **Sinusitis + c-ANCA** -> **Wegener (GPA)**. (ì½§ë¬¼ ì¤„ì¤„ + ì½”í”¼ + ì‹ ì¥).\n3. **[Sx: Can't Hear / Can't See + Hematuria]** -> **[Think: Alport Syndrome]**\n    - **\"Can't see, can't pee, can't hear a bee.\"**\n    - Type IV Collagen ìœ ì „ì ëŒì—°ë³€ì´. (ê°€ì¡±ë ¥ ì¤‘ìš”).\n    - *Biopsy*: **\"Basket-weave\"** appearance (GBMì´ ìª¼ê°œì§).\n### ğŸ§  Mental Framework\n\"ê°ê¸° ê±¸ë¦¬ê³  **'ë°”ë¡œ'**ë©´ IgA, **'í•œì°¸ ë’¤'**ë©´ PSGN. **'í'**ê¹Œì§€ í”¼ í† í•˜ë©´ Goodpasture ì•„ë‹ˆë©´ Wegener.\"\n### 2. RPGN (Rapidly Progressive) - Pulmonary-Renal\n- ğŸ—£ï¸ **Golden Voice**: **\"íì—ì„œ í”¼ í† í•˜ê³  ì½©íŒ¥ë„ ë§ê°€ì§€ë©´ 'Goodpasture' ì•„ë‹ˆë©´ 'Wegener'ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **Goodpasture**: **Anti-GBM í•­ì²´** (Linear IF). ì Šì€ ë‚¨ì.\n    - **Wegener (GPA)**: **c-ANCA** + **ì¶•ë†ì¦/ì½§ë¬¼(Sinusitis)**.\n    - **Alport Syndrome**: **ëˆˆ(Eye) + ê·€(Ear)** + ì½©íŒ¥. (Basket-weave GBM).\n### 3. Nephrotic Syndrome (Protein - Leakage)\n- ğŸ—£ï¸ **Golden Voice**: **\"ì„±ì¸ì´ ë¶“ê³  ë‹¨ë°±ë‡¨ ë‚˜ì˜¤ë©´ 'ê¸°ì €ì§ˆí™˜', ì• ë“¤ì€ ë¬´ì¡°ê±´ 'MCD'ë‹¤.\"**\n- âš¡ **Exam Reflex**:\n    - **íŠ¹ì§•**: ë‹¨ë°±ë‡¨ > 3.5g, ë¶€ì¢…, **Fatty Casts**, Hyperlipidemia.\n- âš”ï¸ **VS ë†€ì´ [ì›ì¸ë³„ ë¶„ë¥˜]**\n1. **[Pt: Child (2-6yo) + Sudden Edema]** -> **[Think: Minimal Change Disease (MCD)]**\n    - í˜„ë¯¸ê²½(LM)ìœ¼ë¡œ ë³´ë©´ ë©€ì©¡í•´(Minimal). ì „ìí˜„ë¯¸ê²½(EM)ìœ¼ë¡œ ë´ì•¼ **Foot process effacement(ë°œ ëŒê¸° ì†Œì‹¤)** ë³´ì„.\n    - *Reflex*: ìƒê²€(Biopsy) í•˜ì§€ ë§ˆ! ê·¸ëƒ¥ ë°”ë¡œ **ìŠ¤í…Œë¡œì´ë“œ(Steroids)** ë•Œë ¤ë°•ìœ¼ë©´ ì”»ì€ ë“¯ì´ ë‚«ëŠ”ë‹¤.\n2. **[Pt: í‘ì¸ Adult + HIV / Heroin / Sickle Cell]** -> **[Think: FSGS]**\n    - ê°€ì¥ í”í•œ ì–´ë¥¸ ì‹ ì¦í›„êµ° ì¤‘ í•˜ë‚˜. í‘ì¸(African American)í•œí…Œ ë§ìŒ.\n    - ìŠ¤í…Œë¡œì´ë“œ? **ì•ˆ ë“¤ì–´.** (Steroid-resistant). ì˜ˆí›„ê°€ ë”ëŸ¬ì›Œ.\n3. **[Pt: Adult + ì•” Hepatitis B/C or SLE or Drugs + í˜ˆì „ìˆìŒ ]** -> **[Think: Membranous Nephropathy]**\n    - ë‘êº¼ì›Œì§„ ê¸°ì €ë§‰ (Thickened GBM).\n    - *Biopsy*: **\"Spike and Dome\"** pattern (ê°€ì‹œì²˜ëŸ¼ ë‹ì•„ë‚¨).\n    - *Risk*: **Renal Vein Thrombosis** (Antithrombin IIIê°€ ì˜¤ì¤Œìœ¼ë¡œ ë¹ ì ¸ì„œ í”¼ê°€ ëˆì í•´ì§). ì˜†êµ¬ë¦¬ ì•„í”„ë‹¤ í•˜ë©´ ì´ê±° ì˜ì‹¬í•´!\n4. **[Pt: Chronic Disease (RA, TB) + Nephrotic]** -> **[Think: Amyloidosis]**\n    - *Biopsy*: **Congo Red Stain** -> **\"Apple-green Birefringence\"** (ì‚¬ê³¼ìƒ‰ í˜•ê´‘). ì´ê±° ë‚˜ì˜¤ë©´ ê²Œì„ ë.\n5. **[Pt: Long-standing Diabetes]** -> **[Think: Diabetic Nephropathy]**\n    - ê°€ì¥ í”í•œ ì›ì¸.\n    - *Biopsy*: **Kimmelstiel-Wilson nodules** (ë™ê¸€ë™ê¸€í•œ ê²°ì ˆ).\n    - *Tx*: ë‹¨ë°±ë‡¨ ë³´ì´ë©´ ë¬´ì¡°ê±´ **ACE inhibitor / ARB** ì¨ì„œ ì§„í–‰ ë§‰ì•„!\n### ğŸ§  Mental Framework\n\"**ì• ë“¤(Child)**ì€ ë¬´ì¡°ê±´ **MCD** (ìŠ¤í…Œë¡œì´ë“œ ì¤˜).\n**ì–´ë¥¸(Adult)**ì€ ì›ì¸ì„ ë´. **ê°ì—¼/ì•½ë¬¼/ìƒ‰ì „ìˆ**ì´ë©´ **Membranous**, í‘ì¸/**HIV/ë§ˆì•½**ì´ë©´ **FSGS**.\n**ë‹¹ë‡¨** í™˜ìëŠ” **ACEi**ê°€ ìƒëª…ì¤„ì´ë‹¤.\"\n---\n## ğŸ¯ Part 5. Structural & Urology (êµ¬ì¡°) - \"ëª¨ì–‘ & ë‚˜ì´\"\n### 1. Kidney Stones (ê²°ì„)\n- ğŸ—£ï¸ **Golden Voice**: **\"ëŒì€ 'ëª¨ì–‘'ìœ¼ë¡œ í‘¼ë‹¤. ë´‰íˆ¬ëŠ” ì¹¼ìŠ˜, ê´€ ëšœê»‘ì€ ê°ì—¼ì´ë‹¤.\"**\n- âš¡ **Exam Reflex**:","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-61","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"**\"X-rayì— ë³´ì´ëƒ ì•ˆ ë³´ì´ëƒ? í˜„ë¯¸ê²½ ëª¨ì–‘ì´ ë­ëƒ?\"**\n1. **[Microscopy: Envelope / Dumbbell Shape]** -> **[Think: Calcium Oxalate]**\n    - ê°€ì¥ í”í•´(80%). X-rayì— í•˜ì–—ê²Œ ì˜ ë³´ì—¬(Radio-opaque).\n    - *ì›ì¸*: **Ethylene Glycol** (ë¶€ë™ì•¡) ë§ˆì…¨ì„ ë•Œë‚˜ **Vit C** ê³¼ë‹¤ ë³µìš©.\n    - *ì¹˜ë£Œ*: **Thiazide Diuretics** (ì¹¼ìŠ˜ ì¬í¡ìˆ˜ ì‹œì¼œì„œ ì†Œë³€ ë‚´ ì¹¼ìŠ˜ ì¤„ì„).\n    - *í•¨ì •*: **Low Calcium Diet í•˜ì§€ ë§ˆ!** (ì˜¤íˆë ¤ ì¥ì—ì„œ Oxalate í¡ìˆ˜ ëŠ˜ì–´ì„œ ëŒ ë” ìƒê¹€).\n2. **[Microscopy: Coffin Lid (ê´€ ëšœê»‘) / Staghorn Calculus]** -> **[Think: Struvite]**\n    - ì›ì¸ì€ **Urease (+) Bugs**: **Proteus**, Saprophyticus, Klebsiella.\n    - ì†Œë³€ì„ **ì•Œì¹¼ë¦¬ì„±(Alkaline)**ìœ¼ë¡œ ë§Œë“¤ì–´ì„œ ìƒê²¨. í•­ìƒì œë§Œìœ¼ë¡  ì•ˆ ë¼, ìˆ˜ìˆ ë¡œ ê¸ì–´ë‚´ì•¼ í•´.\n3. **[X-ray: Invisible (Radio-lucent)]** -> **[Think: Uric Acid]**\n    - **CTì—ëŠ” ë³´ì´ëŠ”ë° X-rayì—” ì•ˆ ë³´ì—¬.**\n    - ëª¨ì–‘ì€ **Rhomboid (ë§ˆë¦„ëª¨)**.\n    - *ì¹˜ë£Œ*: ì†Œë³€ì„ **ì•Œì¹¼ë¦¬í™”(Alkalinization)** ì‹œì¼œë¼ (Potassium Citrate). Allopurinolë„ ì”€.\n4. **[Microscopy: Hexagonal (ìœ¡ê°í˜•)]** -> **[Think: Cystine]**\n    - ì–´ë¦°ì• (Child)ê°€ ëŒ ìƒê²¼ë‹¤? ì´ê±° ì˜ì‹¬í•´. ìœ ì „ë³‘ì´ì•¼.\n    - *ì§„ë‹¨*: **Cyanide-nitroprusside test (+)**.\n### ğŸ§  Mental Framework\n\"**ë´‰íˆ¬(Envelope)**ëŠ” ì¹¼ìŠ˜, **ê´€ ëšœê»‘(Coffin)**ì€ ê· (Proteus), **íˆ¬ëª…ì¸ê°„(Invisible)**ì€ ìš”ì‚°(Uric Acid), **ìœ¡ê°í˜•(Hexagon)**ì€ ì• ë“¤(Cystine).\"\n### 2. Cancer (ì¢…ì–‘)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë…¸ì¸ í¡ì—°ìì˜ í†µì¦ ì—†ëŠ” í˜ˆë‡¨ëŠ” ë¬´ì¡°ê±´ 'ì•”'ì´ë‹¤.\"**\n### âš¡ EXAM REFLEX\n**\"ì–´ë¥¸ì´ëƒ ì• ëƒ? ì•„í”„ëƒ ì•ˆ ì•„í”„ëƒ?\"**\n1. **[Pt: Smoker + Painless Hematuria]** -> **[Think: Bladder Cancer / RCC]**\n    - ì•„í”„ì§€ ì•Šì€ë° í”¼ê°€ ë‚˜ì˜¨ë‹¤? ëŠ™ì€ ë‚¨ì í¡ì—°ìë©´ ë¬´ì¡°ê±´ **ë°©ê´‘ì•”(Urothelial Ca)** ì˜ì‹¬.\n    - *íŠ¹ì´ ì¼€ì´ìŠ¤*: ì´ì§‘íŠ¸ ì—¬í–‰ ê°”ì—ˆë‹¤? -> **Schistosoma** (Squamous Cell Ca).\n2. **[Lab: Polycythemia (High Hct) + Flank Mass]** -> **[Think: RCC]**\n    - ì‹ ì¥ì•” ì„¸í¬ê°€ **EPO**ë¥¼ ë¿œì–´ë‚´ì„œ ì í˜ˆêµ¬ê°€ ë§ì•„ì ¸. (Paraneoplastic).\n    - **VHL gene** (Chromosome 3) ê²°ì†ì´ë‘ ì—°ê´€ë¨. (Clear Cell type).\n    - *ì „ì´*: í(Lung)ë‚˜ ë¼ˆ(Bone)ë¡œ ì˜ ê°. (**Cannonball lesions**).\n3. **[Pt: Child (2-4yo) + Unilateral Flank Mass]** -> **[Think: Wilms Tumor]**\n    - ì—„ë§ˆê°€ ëª©ìš•ì‹œí‚¤ë‹¤ ë°°ì—ì„œ ë©ì–´ë¦¬ ë§Œì ¸ì ¸ì„œ ì˜´.\n    - **ì¤‘ì•™ì„ (Midline)ì„ ì•ˆ ë„˜ì–´ê°!** (ë„˜ì–´ê°€ë©´ Neuroblastoma).\n    - **WAGR complex**: **W**ilms, **A**niridia(í™ì±„ ì—†ìŒ), **G**enitourinary malformation, **R**etardation.\n### ğŸ§  Mental Framework\n\"**í¡ì—°ì í˜ˆë‡¨**ëŠ” ì•”ì´ë‹¤. **RCC**ëŠ” í˜¸ë¥´ëª¬(EPO, PTHrP) ê³µì¥ì´ê³ , **Wilms**ëŠ” ì„ ì„ ì•ˆ ë„˜ëŠ” ì°©í•œ(?) ë©ì–´ë¦¬.\"\n### 3. Cystic Disease (ë¬¼í˜¹)\n- ğŸ—£ï¸ **Golden Voice**: **\"ADPKDëŠ” ì‹ ì¥ë³´ë‹¤ 'ë¨¸ë¦¬(ë‡Œì¶œí˜ˆ)'ê°€ í„°ì ¸ì„œ ì£½ëŠ”ë‹¤.\"**\n**\"ìœ ì „ ë°©ì‹(Dominant vs Recessive)ì´ ë‚˜ì´ì™€ ì˜ˆí›„ë¥¼ ê²°ì •í•´.\"**\n1. **[Pt: Young Adult + HTN + Family Hx]** -> **[Think: ADPKD]**\n    - **A**utosomal **D**ominant = **A**dult. (ì„±ì¸).\n    - ì‹ ì¥ë§Œ ë³´ì§€ ë§ˆ! **ë‡Œë™ë§¥ë¥˜(Berry Aneurysm)** í„°ì ¸ì„œ ì£½ê±°ë‚˜, **ìŠ¹ëª¨íŒ íƒˆì¶œì¦(MVP)** ì˜¨ë‹¤.\n    - *ì¦ìƒ*: ì˜†êµ¬ë¦¬ í†µì¦, í˜ˆë‡¨, ê³ í˜ˆì••.\n2. **[Pt: Newborn + Oligohydramnios (ì–‘ìˆ˜ë¶€ì¡±)]** -> **[Think: ARPKD]**\n    - **A**utosomal **R**ecessive = **P**ediatric. (ì†Œì•„).\n    - ì–‘ìˆ˜ê°€ ë¶€ì¡±í•´ì„œ íê°€ ëª» ìë¼(**Pulmonary Hypoplasia**) -> ìˆ¨ ëª» ì‰¬ì–´ì„œ ì£½ì–´ (**Potter Sequence**).\n    - ê°„(Liver)ë„ êµ³ì–´ (**Hepatic Fibrosis** -> Portal HTN).\n###\n### ğŸ§  Mental Framework\n\"**Dominant(ìš°ì„±)**ëŠ” ì–´ë¥¸, ë‡Œì¶œí˜ˆ ì¡°ì‹¬. **Recessive(ì—´ì„±)**ëŠ” ì• ê¸°, íë‘ ê°„ì´ ë¬¸ì œ.\"\n### 4. UTI (ìš”ë¡œê°ì—¼)\n- ğŸ—£ï¸ **Golden Voice**: **\"ë°©ê´‘ì—¼ì€ ì—´ ì•ˆ ë‚œë‹¤. ì—´ë‚˜ê³  ì˜†êµ¬ë¦¬ ì•„í”„ë©´ 'ì‹ ìš°ì‹ ì—¼'ì´ë‹¤.\"**","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-81","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"### âš¡ EXAM REFLEX\n**\"ì—´ì´ ë‚˜ëƒ(Fever)? ì–¸ì œ ì˜¤ì¤Œì´ ìƒˆëƒ(Leak)?\"**\n1. **[Sx: Dysuria + Suprapubic Pain (No Fever)]** -> **[Think: Cystitis]**\n    - ë°©ê´‘ì—¼. ê· ì€ ëŒ€ì¥ê· (**E. coli**)ì´ 1ë“±. ì Šì€ ì—¬ìëŠ” **Staph. saprophyticus**ë„ ê°€ëŠ¥.\n2. **[Sx: Fever + Flank Pain + WBC Casts]** -> **[Think: Pyelonephritis]**\n    - ì‹ ìš°ì‹ ì—¼. ì˜†êµ¬ë¦¬ ì¹˜ë©´ ìì§€ëŸ¬ì§ (**CVA Tenderness**).\n    - **WBC Casts** ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ ì‹ ì¥ê¹Œì§€ ê· ì´ ì˜¬ë¼ê°„ ê±°ì•¼.\n3. **[Sx: Leak when sneezing/laughing]** -> **[Think: Stress Incontinence]**\n    - ì•  ë§ì´ ë‚³ì€ ì•„ì¤Œë§ˆ. ìš”ë„ ê´„ì•½ê·¼ì´ ì•½í•´ì§.\n    - *ì¹˜ë£Œ*: **Kegel Exercise**.\n4. **[Sx: Sudden strong urge -> Leak]** -> **[Think: Urge Incontinence]**\n    - ê³¼ë¯¼ì„± ë°©ê´‘(Overactive Bladder). ë°©ê´‘ ê·¼ìœ¡ì´ ì§€ ë©‹ëŒ€ë¡œ ìˆ˜ì¶•í•´.\n    - *ì¹˜ë£Œ*: **Anticholinergics** (Oxybutynin) - ë°©ê´‘ ì§„ì •ì‹œì¼œ.\n5. **[Sx: Constant dribbling + Incomplete emptying]** -> **[Think: Overflow Incontinence]**\n    - ê¸¸ì´ ë§‰í˜€ì„œ(BPH) ë„˜ì³íë¥´ëŠ” ê±°ì•¼. ë°©ê´‘ì´ ê½‰ ì°¨ ìˆì–´.\n    - *ì¹˜ë£Œ*: ë§‰íŒ ê±° ëš«ì–´ (**Alpha-blocker**, Foley catheter).\n### ğŸ§  Mental Framework\n\"ì›ƒì„ ë•Œ ìƒˆë©´ **Stress** (ìš´ë™í•´), ëª» ì°¸ê² ìœ¼ë©´ **Urge** (ì•½ ë¨¹ì–´), ì§ˆì§ˆ ìƒˆë©´ **Overflow** (ëš«ì–´).\"","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-101","focus_area":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","tags":["usmle-step2","core","tree"]}
{"chunk_type":"transcript_chunk","text":"# Psy\n![image.png](Psy/image.png)\n- **Mummy (Anticholinergic):**Â Dryí•¨ì„ ê°•ì¡°.\n- **Wet T-shirt (Cocaine):**Â ë•€ë‚˜ê³  í¥ë¶„ ìƒíƒœ.\n- **Slime (Cholinergic):**Â ëª¨ë“  ë¶„ë¹„ë¬¼ì´ ì½¸ì½¸(Leaking).\n- **Kicking leg (SS):**Â Clonus(ë°˜ì‚¬ í•­ì§„) ì‹œê°í™”.\n- **Metal Statue (NMS):**Â Lead-pipe rigidity(ê°•ì§) ì‹œê°í™”.\n![image.png](Psy/image%201.png)\n| **ì§ˆí™˜ (Syndrome)** | **ì›ì¸ (Trigger)** | **ë™ê³µ (Pupil)** | **í”¼ë¶€/ë•€ (Skin)** | **ì¥ìŒ (Bowel)** | **ê·¼ìœ¡/ë°˜ì‚¬ (Muscle) ğŸ”¥** | **í•µì‹¬ ì•”ê¸°ë²• (Mnemonic)** |\n| --- | --- | --- | --- | --- | --- | --- |\n| **SS**Â (Serotonin) | SSRI, Tramadol | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ (ì„¤ì‚¬) | **Clonus (íˆ­ ì¹˜ë©´ íŠ€ì–´ì˜¤ë¦„)** | **S**ky-high Reflex / ìŠ¥ìŠ¥(ë•€, ë°œ) |\n| **NMS**Â (Neuroleptic) | Antipsychotics | **ì •ìƒ (Normal)** | Wet (ê°€ë” Dry) | ì •ìƒ/ê°ì†Œ | **Rigid (ë‚© íŒŒì´í”„ ê°•ì§)** | **N**oÂ **M**ovement /Â **N**o **M**ydriasis |\n| **MH**Â (Malignant Hyper) | ë§ˆì·¨ì œ (Succinyl) | ì •ìƒ (Normal) | Wet | ê°ì†Œ | **Rigid (í„±ë¶€í„° êµ³ìŒ)** | ìˆ˜ìˆ ë°©ì—ì„œ ë¶ˆë‚¬ë‹¤ |\n| **DT**Â (Delirium T) | Alcohol ëŠìŒ | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ | **Tremor (ì „ì‹  ë–¨ë¦¼)** | **D**olÂ **D**ol (ëœëœ) / D(dual)T(tri) = 2-3ì¼ / D for ëœëœ T for tachycardia |\n| **Sympathomimetic** | Cocaine, Meth | **í™•ëŒ€ (Big)** | **Wet. êµê°ì‹ ê²½ì´ì–´ë„ ì‹¬ì¥ì´ ê³¼ë¶€í™”ë˜ì–´ ë°œì—´, ì—´ì‹íˆë ¤ê³  ë•€ë‚¨.** | ì¦ê°€ | ê¸´ì¥ë¨ (Not Rigid) | **C**razyÂ **W**et (ë¯¸ì¹œ ë“¯ì´ ì –ìŒ) |\n| **Anticholinergic** | Atropine | **í™•ëŒ€ (Big)** | **DRY (í•µì‹¬!)** | **ê°ì†Œ (ë³€ë¹„)** | ì •ìƒ/Clonus ë“œë¬¾ | **ì‚¬ë§‰**ì˜ í† ë¼ (ë¹¨ê°›ê³  ë§ˆë¥´ê³  ëˆˆ í¼)\na-DRY-pine. Antiì½¸ì½¸ |\n| **Cholinergic** | ë†ì•½, Nerve gas | **ì¶•ì†Œ (Pinpoint)** | **WET (í™ìˆ˜)** | **ì¦ê°€ (ì„¤ì‚¬)** | ìœ„ì•½ê°, Fasciculation | **ì½¸ì½¸**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒ˜) |\n### 1. Serotonin Syndrome (SS)\n- **One-Line Vibe:**Â **\"ì –ì€ ì±„ë¡œ í„ì© ë›°ëŠ” ì‚¬ë§‰ ì•„ì €ì”¨\"**Â (ê³ ì—´ + ë•€ + ê·¼ìœ¡ íŠ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"S\"**haking, **\"S\"**weating, **\"S\"**ky-high reflex\n    - **ìŠ¥ìŠ¥:**Â ë•€ ë‹¦ëŠë¼Â **ìŠ¥ìŠ¥**, ë°œëª© ì¹˜ë©´Â **ìŠ¥ìŠ¥**Â íŠ€ì–´ ì˜¤ë¦„ (**Clonus**).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.\n![image.png](Psy/image%202.png)\n### 2. Neuroleptic Malignant Syndrome (NMS)\n- **One-Line Vibe:**Â **\"ë¶ˆíƒ€ëŠ” ë‚© ë™ìƒ\"**Â (ê³ ì—´ + ë•€ + ê¼¼ì§ë„ ì•ˆ í•¨)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"N\"**o **\"M\"**otion **\"S\"**yndrome\n    - **No Motion:**Â ê·¼ìœ¡ì´ ë‚© íŒŒì´í”„ì²˜ëŸ¼ êµ³ìŒ (**Lead-pipe Rigidity**).\n    - **Normal Pupil:**Â ë™ê³µì€ ë³´í†µÂ **ì •ìƒ**Â (SSì™€ ê²°ì •ì  ì°¨ì´!).\n### 3. Delirium Tremens (DT)\n- **One-Line Vibe:**Â **\"ìˆ  ëŠê³  ì°¾ì•„ì˜¨ í­í’\"**Â (ë¯¸ì¹œ ë“¯í•œ ë–¨ë¦¼ + ììœ¨ì‹ ê²½ í­ì£¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"D\"**ual - **\"T\"**ri (2-3) &Â **\"ëœëœ\"**\n    - **Dual-Tri:**Â **2~3ì¼(48~72h)**Â í›„ í”¼í¬ íƒ€ì„.\n    - **ëœëœ:**Â ì˜¨ëª¸ì„Â **ëœëœ**Â ë–ª (**Tremor**).\n    - **T:**Â **T**achycardia &Â **T**emperature (ì‹¬ì¥ ë›°ê³  ì—´ ë‚¨).\n### 4. Anticholinergic (Atropine)\n- **One-Line Vibe:**Â **\"ì‚¬ë§‰ì— ê³ ë¦½ëœ ë¯¸ì¹œ í† ë¼\"**Â (ë°”ì§ ë§ˆë¦„ + ë¹¨ê°œì§ + ëˆˆ í¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"A-Dry-Pine\"**Â &Â **\"Anti-Cola\"**\n    - **A-Dry-Pine:**Â ì•„íŠ¸ë¡œí•€ì€Â **Dry**í•˜ë‹¤ (ê²¨ë“œë‘ì´ ë½€ì†¡ë½€ì†¡ =Â **í•µì‹¬ ê°ë³„ì **).\n    - **Anti-Cola:**Â ì•ˆí‹°-ì½œë¼ë¼Â **ëª©ë§ë¼**Â (ì¹¨ë„ ì•ˆ ë‚˜ì˜´).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**Â & ì™•ëˆˆì´ í† ë¼.\n![image.png](Psy/image%203.png)\n### 5. Cholinergic (Organophosphate/ë†ì•½)\n- **One-Line Vibe:**Â **\"ìˆ˜ë„ê¼­ì§€ ê³ ì¥ ë‚œ ë¬¼í’ì„ \"**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒœìŒ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"Chol\"**inergic = **\"ì½¸\"**ë¦¬ë„ˆì§\n    - **ì½¸ì½¸:**Â ëˆˆë¬¼, ì¹¨, ë•€, ì„¤ì‚¬, ì†Œë³€ ë‹¤ ì½¸ì½¸ (**Wet í™ìˆ˜**).\n    - **Pupil:**Â **ì¶•ì†Œ (Pinpoint)**Â (ìˆ˜ì•• ë•Œë¬¸ì— ìª¼ê·¸ë¼ë“¦).\n### 6. Sympathomimetic (Cocaine)\n- **One-Line Vibe:**Â **\"ëƒ‰ê°ìˆ˜ í„°ì§„ ìŠ¤í¬ì¸ ì¹´\"**Â (í’€ ì—‘ì…€ + ë•€ë²”ë²…)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"C\"**razy **\"W\"**et\n    - **Wet:**Â êµê°ì‹ ê²½ í•­ì§„ì¸ë°Â **ë•€ì´ ë‚¨**Â (Anticholinergicê³¼ ë°˜ëŒ€!).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.\n![image.png](Psy/image%204.png)","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-1","focus_area":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","tags":["usmle-step2","core","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"![image.png](Psy/image%205.png)\n![image.png](Psy/image%206.png)\n---\n![image.png](Psy/image%207.png)\nì¹˜ë£Œ: NahCo3\n![image.png](Psy/image%208.png)\n![image.png](Psy/image%209.png)\n![image.png](Psy/image%2010.png)\n![image.png](Psy/image%2011.png)\n![image.png](Psy/image%2012.png)\n![image.png](Psy/image%2013.png)\n![image.png](Psy/image%2014.png)\n![image.png](Psy/image%2015.png)\nì•”ê¸°ë²• 2: \"G-P\" (ë‹¤ë¦¬ë¥¼ ê³ ì •í•˜ëŠ” í•€)\në‹¤ë¦¬ê°€ ì œë©‹ëŒ€ë¡œ ì›€ì§ì´ë ¤ê³  í•  ë•Œ, ë°”ë‹¥ì— ê³ ì •í•´ë²„ë¦¬ëŠ” ì´ë¯¸ì§€ë¥¼ ë– ì˜¬ë ¤ë´.\nStory: ëœëœê±°ë¦¬ê³  ì›€ì§ì´ëŠ” ë‹¤ë¦¬ë¥¼ Ground(ë°”ë‹¥)ì— Pin(í•€)ìœ¼ë¡œ ê½‚ì•„ì„œ ê³ ì •í•´ë²„ë¦¬ì.\nMnemonic: G-P (Ground-Pin)\nG: Gabapentin\nP: Pregabalin\nì—°ê²°: ì›€ì§ì´ëŠ” ë‹¤ë¦¬ë¥¼ ê³ ì •(Pin)í•˜ëŠ” G-P ì½¤ë¹„!","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-21","focus_area":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","tags":["usmle-step2","core","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# Psy and number\nUSMLE Step 2 ì¤€ë¹„ ê³¼ì •ì—ì„œ ì •ì‹ ê³¼ ì§ˆí™˜ì˜ ì§„ë‹¨ ê¸°ì¤€, íŠ¹íˆ 'ìˆ«ì(ê¸°ê°„, ë‚˜ì´, ë¹ˆë„)'ê°€ í—·ê°ˆë¦¬ëŠ” ê²ƒì€ ë§¤ìš° í”í•œ ì¼ì…ë‹ˆë‹¤. ì •ì‹ ê³¼ ì§„ë‹¨ì€ ì¦ìƒì˜ **ì§€ì† ê¸°ê°„(Duration)**ê³¼ **ë°œë³‘ ì—°ë ¹(Onset Age)**ì´ ë‹¤ë¥¸ ì§ˆí™˜ê³¼ì˜ ê°ë³„ í¬ì¸íŠ¸(Differential Diagnosis)ê°€ ë˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤.\nì œê³µí•´ì£¼ì‹  ìë£Œë¥¼ ë°”íƒ•ìœ¼ë¡œ, ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” í—·ê°ˆë¦¬ëŠ” ì§ˆí™˜ë“¤ì„ 'ìˆ«ì'ë¥¼ ì¤‘ì‹¬ìœ¼ë¡œ ì¬êµ¬ì„±í•˜ì—¬ ì •ë¦¬í•´ ë“œë¦½ë‹ˆë‹¤.\n1. íƒ€ì„ë¼ì¸ psychotic :1, 6\n2. stress: 1ê¸°ì¤€ìœ¼ë¡œ ë°”ë€œ\n3. anxiety: 6ê°œì›”ì´ìƒ\n4. ê¸°ë¶„ì¥ì•  2ì˜ ë²•ì¹™. ë§Œì„± 2ë…„ì´ìƒ\n---\n### **1. Psychotic Disorders (ì •ì‹ ë³‘ì  ì¥ì• ): \"ê¸°ê°„\"ì´ ì§„ë‹¨ëª…ì´ë‹¤**\nì´ íŒŒíŠ¸ì˜ í•µì‹¬ì€ ì¦ìƒ(ë§ìƒ, í™˜ê° ë“±)ì€ ê°™ì§€ë§Œ, **ì¦ìƒì´ ì–¼ë§ˆë‚˜ ì§€ì†ë˜ì—ˆëŠ”ê°€**ì— ë”°ë¼ ì§„ë‹¨ëª…ì´ ë°”ë€ë‹¤ëŠ” ì ì…ë‹ˆë‹¤.\n- **General Rule:** ì¦ìƒì´ 1ê°œì›” ë¯¸ë§Œì´ë©´ Brief, 6ê°œì›” ë„˜ìœ¼ë©´ Schizophrenia, ê·¸ ì‚¬ì´ë©´ Schizophreniformì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Brief Psychotic Disorder** | **1ì¼ ì´ìƒ ~ 1ê°œì›” ë¯¸ë§Œ** | ê¸‰ê²©í•œ ë°œë³‘, ê¸°ëŠ¥ì˜ ì™„ì „í•œ íšŒë³µ. |\n| **Schizophreniform Disorder** | **1ê°œì›” ì´ìƒ ~ 6ê°œì›” ë¯¸ë§Œ** | Schizophreniaì™€ ì¦ìƒì€ ê°™ìœ¼ë‚˜, ì‚¬íšŒì /ì§ì—…ì  ê¸°ëŠ¥ ì €í•˜ëŠ” í•„ìˆ˜ ì•„ë‹˜. |\n| **Schizophrenia** | **6ê°œì›” ì´ìƒ** | í™œì„±ê¸° ì¦ìƒ(Active symptoms) 1ê°œì›” ì´ìƒ í¬í•¨, ê¸°ëŠ¥ ì €í•˜ í•„ìˆ˜. |\n| **Delusional Disorder** | **1ê°œì›” ì´ìƒ** | ê¸°ì´í•˜ì§€ ì•Šì€ í–‰ë™, ë§ìƒ ì™¸ì—ëŠ” ê¸°ëŠ¥ì´ ì •ìƒì ì„. |\n| **Schizoaffective Disorder** | **2ì£¼ (2 weeks)** | í‰ìƒ ë™ì•ˆ ê¸°ë¶„ ì‚½í™”(Mood episode) **ì—†ì´** ë§ìƒì´ë‚˜ í™˜ê°ë§Œ ìˆëŠ” ê¸°ê°„ì´ **2ì£¼ ì´ìƒ** ìˆì–´ì•¼ í•¨ (ê¸°ë¶„ ì¥ì• ì™€ ê°ë³„í•˜ëŠ” í•µì‹¬ í¬ì¸íŠ¸). |\n---\n### **2. Mood Disorders (ê¸°ë¶„ ì¥ì• ): \"ê¸‰ì„± vs ë§Œì„±\" 2**\nê¸°ë¶„ ì¥ì• ëŠ” **ì‚½í™”(Episode)ì˜ ì§€ì† ê¸°ê°„**ê³¼ **ë§Œì„±ë„(Chronicity)**ê°€ ìˆ«ìì˜ í•µì‹¬ì…ë‹ˆë‹¤.\n- **General Rule:** ManiaëŠ” ì‘ê¸‰ ìƒí™©(ì…ì› ë˜ëŠ” 1ì£¼), HypomaniaëŠ” 4ì¼, ìš°ìš¸ì¦ì€ 2ì£¼ì…ë‹ˆë‹¤. ë§Œì„±(Chronic)ì´ ë¶™ìœ¼ë ¤ë©´ ì„±ì¸ì€ 2ë…„ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Manic Episode** | **1ì£¼ ì´ìƒ** (í˜¹ì€ ì…ì› í•„ìš” ì‹œ ì¦‰ì‹œ) | ì‹¬ê°í•œ ì‚¬íšŒì  ê¸°ëŠ¥ ì†ìƒ. |\n| **Hypomanic Episode** | **4ì¼ ì´ìƒ** (ì—°ì†) | ê¸°ëŠ¥ì˜ ë³€í™”ëŠ” ìˆìœ¼ë‚˜ ì…ì›í•  ì •ë„ëŠ” ì•„ë‹˜. |\n| **Major Depressive Disorder (MDD)** | **2ì£¼ ì´ìƒ** | ìš°ìš¸ ê¸°ë¶„ í¬í•¨ 5/9 ì¦ìƒ ì¶©ì¡±. |\n| **Persistent Depressive Disorder (Dysthymia)** | **2ë…„ ì´ìƒ** (ì†Œì•„/ì²­ì†Œë…„ì€ 1ë…„) | ë¬´ì¦ìƒ ê¸°ê°„ì´ **2**ê°œì›”ì„ ë„˜ì§€ ì•ŠìŒ. |\n| **Cyclothymic Disorder** | **2ë…„ ì´ìƒ** | ê²½ë¯¸í•œ Hypomanic/Depressive ì¦ìƒì˜ ë°˜ë³µ (MDD ê¸°ì¤€ ë§Œì¡± X), ì •ìƒ ê¸°ê°„ 2ê°œì›” ë¯¸ë§Œ,. |\n| **Adjustment Disorder** | **3ê°œì›” ì´ë‚´** ë°œë³‘ | ìŠ¤íŠ¸ë ˆìŠ¤ ìš”ì¸ ë°œìƒ í›„ 3ê°œì›” ë‚´ ì‹œì‘. ë‹¤ë¥¸ ì •ì‹  ì§ˆí™˜ ê¸°ì¤€ì„ ë§Œì¡±í•˜ì§€ ì•Šì•„ì•¼ í•¨. |\n| **Rapid Cycling (Bipolar)** | **12ê°œì›” ë‚´ 4íšŒ ì´ìƒ** | 1ë…„ ë™ì•ˆ 4ë²ˆ ì´ìƒì˜ ê¸°ë¶„ ì‚½í™” ë°œìƒ. |\n---\n### **3. Anxiety & Trauma (ë¶ˆì•ˆ ë° ì™¸ìƒ): \"1ê°œì›”ê³¼ 6ê°œì›”ì˜ ë²•ì¹™\"**\në¶ˆì•ˆ ì¥ì• ëŠ” ì¼ì‹œì ì¸ ë°˜ì‘ê³¼ ë³‘ì ì¸ ìƒíƒœë¥¼ êµ¬ë¶„í•˜ê¸° ìœ„í•´ íŠ¹ì • ê¸°ê°„ì„ ìš”êµ¬í•©ë‹ˆë‹¤.\n- **General Rule:** íŠ¸ë¼ìš°ë§ˆ ê´€ë ¨ì€ **1ê°œì›”**ì„ ê¸°ì¤€ìœ¼ë¡œ ë³‘ëª…ì´ ë°”ë€ë‹ˆë‹¤. ì¼ë°˜ì ì¸ ë¶ˆì•ˆ/ê³µí¬ì¦ì€ **6ê°œì›”** ì´ìƒ ì§€ì†ë˜ì–´ì•¼ ì§„ë‹¨í•©ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Acute Stress Disorder (ASD)** | **3ì¼ ì´ìƒ ~ 1ê°œì›” ì´ë‚´** | íŠ¸ë¼ìš°ë§ˆ í›„ 1ê°œì›” ë‚´ ì¦ìƒ ë°œìƒ ë° ì¢…ë£Œ. |\n| **Post-Traumatic Stress Disorder (PTSD)** | **1ê°œì›” ì´ˆê³¼** | íŠ¸ë¼ìš°ë§ˆ í›„ ì¦ìƒì´ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Panic Disorder** | **1ê°œì›” ì´ìƒ** | ê³µí™© ë°œì‘ í›„, ì¶”ê°€ ë°œì‘ì— ëŒ€í•œ ê±±ì •ì´ë‚˜ íšŒí”¼ê°€ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Generalized Anxiety Disorder (GAD)** | **6ê°œì›” ì´ìƒ** | í†µì œí•˜ê¸° í˜ë“  ê³¼ë„í•œ ê±±ì •. |\n| **Specific Phobia** | **6ê°œì›” ì´ìƒ** | íŠ¹ì • ëŒ€ìƒì— ëŒ€í•œ í˜„ì €í•œ ê³µí¬. |\n| **Social Anxiety Disorder** | **6ê°œì›” ì´ìƒ** | ì‚¬íšŒì  ìƒí™©ì— ëŒ€í•œ ë¶ˆì•ˆ. |\n---","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-1","focus_area":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"### **4. Childhood Disorders (ì†Œì•„ ì§ˆí™˜): \"ë‚˜ì´ì™€ ì§€ì† ê¸°ê°„\"**\nì†Œì•„ê³¼ëŠ” **\"ëª‡ ì‚´ë¶€í„° ì§„ë‹¨ ê°€ëŠ¥í•œê°€?\"**ì™€ **\"ì¦ìƒì´ ì–¸ì œ ì‹œì‘ë˜ì—ˆëŠ”ê°€?\"**ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **General Rule:** ë°°ì„¤ ì¥ì• ëŠ” ë°œë‹¬ ì—°ë ¹(4~5ì„¸)ì„ ê³ ë ¤í•´ì•¼ í•˜ë©°, ADHDëŠ” 12ì„¸ ì´ì „ ë°œë³‘ì´ í•„ìˆ˜ì…ë‹ˆë‹¤.\n- 5ì¤Œ\n- 4ë³€\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ë‚˜ì´/ê¸°ê°„ (Key Age/Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **ADHD** | **12ì„¸ ì´ì „** ë°œë³‘ / **6ê°œì›” ì´ìƒ** ì§€ì† | ë‘ êµ°ë° ì´ìƒì˜ ì¥ì†Œ(ì§‘, í•™êµ ë“±)ì—ì„œ ì¦ìƒ ë°œí˜„. |\n| **Tourette Syndrome** | **18ì„¸ ì´ì „** ë°œë³‘ / **1ë…„ ì´ìƒ** ì§€ì†\nddx. ì•„ë™ê¸° ì¼ê³¼ì„± í‹±ì¥ì•  | ìš´ë™ í‹±(Motor) + ìŒì„± í‹±(Vocal)ì´ ëª¨ë‘ ìˆì–´ì•¼ í•¨ (ë™ì‹œì¼ í•„ìš”ëŠ” ì—†ìŒ). |\n| **Encopresis (ìœ ë¶„ì¦)** | **4ì„¸ ì´ìƒ** | ëŒ€ë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Enuresis (ìœ ë‡¨ì¦)** | **5ì„¸ ì´ìƒ** | ì†Œë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Reactive Attachment Disorder** | **5ì„¸ ì´ì „** ì§•í›„ | ë°©ì„ ë“±ìœ¼ë¡œ ì¸í•´ ì–‘ìœ¡ìì—ê²Œ ì •ì„œì  ë°˜ì‘ì„ ë³´ì´ì§€ ì•ŠìŒ. |\n| **Oppositional Defiant Disorder (ODD)** | **6ê°œì›” ì´ìƒ** | ê¶Œìœ„ì— ëŒ€í•œ ì ëŒ€ì , ë°˜í•­ì  í–‰ë™ íŒ¨í„´. |\n| **Intermittent Explosive Disorder** | **6ì„¸ ì´í›„** ë°œë³‘ / ë°œì‘ **30ë¶„ ë¯¸ë§Œ(ì§§ê°•)**\n**vs. disruptive DMDD:** 10ì„¸ì´ì „. 6ì„¸ì´ì „ 18ì„¸ ì´í›„ ì§„ë‹¨ë¶ˆê°€. ì‚¬ì´ì‚¬ì´ì—ë„ í™”ë‚˜ìˆìŒ. ì§€ì†ì  | ë„ë°œì— ë¹„í•´ ê³¼ë„í•œ ê³µê²©ì„±, ê³„íšë˜ì§€ ì•ŠìŒ. í›„íšŒ. |\n---\n### **5. Somatic & Eating Disorders (ì‹ ì²´ ë° ì„­ì‹ ì¥ì• ): \"ë¹ˆë„ì™€ ìˆ˜ì¹˜\"**\n- **General Rule:** ì„­ì‹ ì¥ì• ëŠ” **3ê°œì›”** ë™ì•ˆ **ì£¼ 1íšŒ** ì´ìƒ í–‰ë™ì´ ë°˜ë³µë˜ì–´ì•¼ í•˜ë©°, AnorexiaëŠ” ì²´ì¤‘(BMI)ì´ ê²°ì •ì ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ìˆ˜ì¹˜ (Key Metrics)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Anorexia Nervosa** | **BMI < 18.5 kg/mÂ²** | ì €ì²´ì¤‘ì´ í•„ìˆ˜ ì§„ë‹¨ ê¸°ì¤€. ì…ì› ê¸°ì¤€ì€ **BMI < 15** ë˜ëŠ” í™œë ¥ì§•í›„ ë¶ˆì•ˆì •,. |\n| **Bulimia Nervosa** | **ì£¼ 1íšŒ ì´ìƒ, 3ê°œì›”ê°„** | í­ì‹ + ë³´ìƒ í–‰ë™(êµ¬í†  ë“±). ì²´ì¤‘ì€ ì •ìƒì´ê±°ë‚˜ ê³¼ì²´ì¤‘ì¼ ìˆ˜ ìˆìŒ. |\n| **Somatic Symptom Disorder** | **6ê°œì›” ì´ìƒ** | 1ê°œ ì´ìƒì˜ ì‹ ì²´ ì¦ìƒ + ê³¼ë„í•œ ê±±ì •/ì‹œê°„ ì†Œë¹„. |\n| **Gender Dysphoria** | **6ê°œì›” ì´ìƒ** | ì§€ì •ëœ ì„±ë³„ê³¼ ê²½í—˜í•˜ëŠ” ì„±ë³„ì˜ ë¶ˆì¼ì¹˜ë¡œ ì¸í•œ ê³ í†µ. |\n---\n### **6. ì•½ë¬¼ ë° ì¹˜ë£Œ ê´€ë ¨ ìˆ«ì (Pharmacology & Management)**\n- **Antidepressant Trial:** ì¹˜ë£Œ íš¨ê³¼ë¥¼ íŒì •í•˜ê¸° ìœ„í•´ **4~6ì£¼** ë™ì•ˆ ì¹˜ë£Œ ìš©ëŸ‰ì„ ìœ ì§€í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Maintenance Therapy (ìš°ìš¸ì¦):**\n    - ì²« ë°œë³‘(Single episode): ê´€í•´ í›„ **6ê°œì›”** ì¶”ê°€ ìœ ì§€.\n    - ì¬ë°œ(Recurrent): **1~3ë…„** ë˜ëŠ” ë¬´ê¸°í•œ ìœ ì§€.\n- **Alcohol Withdrawal Timeline:**\n    - 6-24ì‹œê°„: ê²½ë¯¸í•œ ì¦ìƒ, ë¶ˆì•ˆ, ë–¨ë¦¼.\n    - 12-48ì‹œê°„: ë°œì‘(Seizures), ì•Œì½”ì˜¬ í™˜ê°(Alcoholic hallucinosis - ì˜ì‹ ëª…ë£Œí•¨).\n    - 48-96ì‹œê°„: ì§„ì „ ì„¬ë§(Delirium Tremens - ì˜ì‹ í˜¼íƒ, í™œë ¥ì§•í›„ ë¶ˆì•ˆì •).\nì´ ì •ë¦¬ê°€ USMLE Step 2 ì¤€ë¹„ì— í° ê·¸ë¦¼ì„ ê·¸ë¦¬ëŠ” ë° ë„ì›€ì´ ë˜ê¸°ë¥¼ ë°”ëë‹ˆë‹¤. íŠ¹íˆ **2ì£¼(Schizoaffective)**, **1ê°œì›”(Psychosis/PTSD ê²½ê³„)**, **6ê°œì›”(Anxiety/Schizophrenia)** ê°™ì€ ê¸°ì¤€ì ë“¤ì€ ì‹œí—˜ì— ë¹ˆì¶œë˜ë¯€ë¡œ ê¼­ ìˆ™ì§€í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-21","focus_area":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Cardio\n- **K+ (ê°€ì¶œ ì†Œë…„):**Â í‰ì†Œì—” 'ì „ì•• ì¶©ì „', ë‚˜ì¤‘ì—” 'ì „ì•• ë¦¬ì…‹'ì„ ë‹´ë‹¹í•˜ëŠ”Â **ë‚˜ê°€ëŠ” ë†ˆ.**\n    - ì„¸í¬ì•ˆì— K+ê°€ ë§ì€ë° ê³„ì† ê°€ì¶œí•´ â†’ RMP ìŒì „í•˜\n    - ë‚˜ì¤‘ì— phase 3ë•Œ ì¬ë¶„ê·¹ë•Œ  K+ [í¬]íƒ€ìŠ˜ì´ [í¬]ê¸° í•˜ê³  ë‚˜ê°€ë©´ì„œ íƒˆë¶„ê·¹ì„ ë‹¤ì‹œ ìŒì „í•˜ë¡œ ì¬ë¶„ê·¹.\n- **Na+ (ë‚˜ ì§€ê¸ˆ ë“¤ì–´ê°€!):**Â ì‹¬ì¥ ìˆ˜ì¶•ì˜ ë°©ì•„ì‡ ë¥¼ ë‹¹ê¸°ëŠ”Â **ì³ë“¤ì–´ì˜¤ëŠ” ë†ˆ.**\n- **Pump (í•˜ìš°ìŠ¤í‚¤í¼):**Â ì´ ëª¨ë“  ê°œíŒ(?)ì„ ì •ë¦¬í•˜ê³ Â Na+ëŠ” ë°–ìœ¼ë¡œ K+ì€ ì•ˆìœ¼ë¡œ **ìœ„ì¹˜ ì‹œí‚¤ëŠ” ì—„ë§ˆ.**\n**[ì „ì•¼ì œ: í‰í™”ë¡œì›Œ ë³´ì´ì§€ë§Œ ê°€ì¥ ë°”ìœ 'ì¶©ì „' ì‹œê°„]**\n![image.png](Cardio/image.png)\në¬´ëŒ€ì˜ ì£¼ì¸ê³µì€ **'í•˜ìš°ìŠ¤í‚¤í¼(Na/K íŒí”„)'**ì•¼. ì–˜ëŠ” ì—ë„ˆì§€ë¥¼ íŒíŒ ì¨ê°€ë©° ì§‘ì•ˆ(ì„¸í¬ ì•ˆ)ìœ¼ë¡œ ì„±ê²© ê¸‰í•œ **'ê°€ì¶œ ì†Œë…„(í¬íƒ€ìŠ˜)'**ë“¤ì„ ì–µì§€ë¡œ ëŒì–´ë‹¤ ë†“ê³ , ê¸°ì›ƒê±°ë¦¬ë˜ **'ë‚˜íŠ¸ë¥¨ ë¶ˆëŸ‰ë°°'**ë“¤ì€ ë°–ìœ¼ë¡œ ì°¨ë²„ë ¤.\nê·¸ëŸ°ë° ë¬¸ì œê°€ ìƒê²¨. ì´ ê°€ì¶œ ì†Œë…„ë“¤ì´ ë„ˆë¬´ ë‹µë‹µí•œ ë‚˜ë¨¸ì§€, ì„¸í¬ë§‰ì— ëš«ë¦° ì‘ì€ ìª½ë¬¸(leak k+ channel) ìœ¼ë¡œ ìê¾¸ë§Œ ë°–ìœ¼ë¡œ ë„ë§ì„ ê°€ë²„ë¦¬ëŠ” ê±°ì•¼. [ì¹´]ã„¹ë¥¨ : [ì¹´]ì¶œ\n(ë°–ì— hyperkalemiaë©´ ëœ ê°€ì¶œí•¨. ëœ ê°€ì¶œí•˜ë‹ˆ ëœ ìŒì „í•˜ -70ì •ë„)\ní”ŒëŸ¬ìŠ¤(+) ì„±ì§ˆì„ ê°€ì§„ ì†Œë…„ë“¤ì´ ìê¾¸ ë‚˜ê°€ë²„ë¦¬ë‹ˆê¹Œ, ì§‘ì•ˆì€ ê²°êµ­ í…… ë¹„ê³ Â **'ì™¸ë¡œìš´ ë§ˆì´ë„ˆìŠ¤(-90mV)'**Â ìƒíƒœê°€ ë¼. í•˜ì§€ë§Œ ì´ê±´ ë¶ˆí–‰ì´ ì•„ë‹ˆì•¼. ì„¸í¬ëŠ” ì¼ë¶€ëŸ¬ ì´ 'ì™¸ë¡œì›€(ì „ì••)'ì„ ìœ ì§€í•˜ê³  ìˆëŠ” ê±°ì•¼.\nì–¸ì œë“  ë°–ì˜ ë‚˜íŠ¸ë¥¨ì´ ì³ë“¤ì–´ì˜¬ ë•Œ í­ë°œì ì¸ ë°˜ì‘ì„ ë³´ì¼ ìˆ˜ ìˆë„ë¡ ì—ë„ˆì§€ë¥¼Â **'í’€ì¶©ì „'**Â í•´ë†“ì€ ìƒíƒœì¸ ê±°ì§€.\n**[ì œ1ë§‰: ë‚˜íŠ¸ë¥¨ì˜ ì¹¨ê³µê³¼ ì¹¼ìŠ˜ì˜ ì§€ì›]**\n![image.png](Cardio/image%201.png)\nì´ë•Œ ê°‘ìê¸° ë°–ì—ì„œ ëŒ€ê¸°í•˜ë˜ **'ë‚˜íŠ¸ë¥¨(Na)'**ë“¤ì´\n\"ë‚˜(Na) ì§€ê¸ˆ ë“¤ì–´ê°„ë‹¤!\"\në¼ê³  ì†Œë¦¬ì¹˜ë©° ì •ë¬¸ì„ ë°•ì°¨ê³  ìŸì•„ì ¸ ë“¤ì–´ì™€.\nì™¸ë¡œì› ë˜ ì§‘ì•ˆì€ ìˆœì‹ê°„ì— í”ŒëŸ¬ìŠ¤(+) ê¸°ìš´ìœ¼ë¡œ ê°€ë“ ì°¨ë©° ì—´ê´‘ì˜ ë„ê°€ë‹ˆê°€ ë˜ì§€. ì´ê²Œ ë°”ë¡œ ì‹¬ì¥ì´ ìˆ˜ì¶•ì„ ì‹œì‘í•˜ëŠ” **'íƒˆë¶„ê·¹'**ì´ì•¼. ê·¸ëŸ°ë° ë‚˜íŠ¸ë¥¨ë§Œìœ¼ë¡œëŠ” í˜ì´ ì¢€ ë¶€ì¡±í•´.\nê·¸ë˜ì„œ **'ì¹¼ìŠ˜(Ca)'**ì´ë¼ëŠ” ë©ì¹˜ í° ì¹œêµ¬ê°€ ë’¤ë”°ë¼ ë“¤ì–´ì™€. ì¹¼ìŠ˜ì€ ì§‘ì•ˆì— ë¨¸ë¬¼ë©´ì„œ ì‹¬ì¥ ê·¼ìœ¡ì´ \"ìœ¼ëì°¨ì°¨!\" í•˜ê³  í”¼ë¥¼ ì§œë‚¼ ìˆ˜ ìˆê²Œ ì‹œê°„ì„ ë²Œì–´ì£¼ê³  í˜ì„ ë³´íƒœì¤˜.\n**[ì œ2ë§‰: ê°€ì¶œ ì†Œë…„ì˜ ì§‘ë‹¨ íƒˆì¶œê³¼ ë¦¬ì…‹]**\n![image.png](Cardio/image%202.png)\nì¶•ì œê°€ ì˜ì›í•  ìˆœ ì—†ê² ì§€? íŒŒí‹°ê°€ ëë‚  ë•Œì¯¤, ì•„ì§ë„ ì•ˆì— ë” ìˆë˜ **'ê°€ì¶œ ì†Œë…„(í¬íƒ€ìŠ˜)'**ë“¤ì´ ì´ë²ˆì—” ìª½ë¬¸ì´ ì•„ë‹ˆë¼ ***'ì •ë¬¸'***ì„ ì—´ê³  ë–¼ê±°ì§€ë¡œ ë°–ìœ¼ë¡œ ë‚˜ê°€ë²„ë ¤.","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-1","focus_area":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"í”ŒëŸ¬ìŠ¤ ì´ì˜¨ë“¤ì´ ë¬´ë”ê¸°ë¡œ ë¹ ì ¸ë‚˜ê°€ë‹ˆê¹Œ, ëœ¨ê±°ì› ë˜ ì§‘ì•ˆ ì—´ê¸°ëŠ” ìˆœì‹ê°„ì— ì‹ì–´ë²„ë¦¬ê³  ë‹¤ì‹œ ì°¨ê°€ìš´Â **'ë§ˆì´ë„ˆìŠ¤'**Â ìƒíƒœë¡œ ëŒì•„ê°€ê²Œ ë¼. ì´ê±¸ **'ì¬ë¶„ê·¹'**ì´ë¼ê³  ë¶ˆëŸ¬.\n**[ì œ3ë§‰: í•˜ìš°ìŠ¤í‚¤í¼ì˜ ë’·ì •ë¦¬]**\nì´ì œ ì§‘ì•ˆì€ ì—‰ë§ì§„ì°½ì´ì•¼. ì›ë˜ ì•ˆì— ìˆì–´ì•¼ í•  í¬íƒ€ìŠ˜ì€ ë°–ì— ìˆê³ , ë°–ì— ìˆì–´ì•¼ í•  ë‚˜íŠ¸ë¥¨ê³¼ ì¹¼ìŠ˜ì€ ì•ˆì— ë“¤ì–´ì™€ ìˆì§€.\nì´ë•Œ ë‹¤ì‹œ ìš°ë¦¬ì˜ **'í•˜ìš°ìŠ¤í‚¤í¼(íŒí”„)'**ê°€ ë“±íŒí•´. íˆ¬ëœëŒ€ë©´ì„œë„ **ë“¤ì–´ì˜¨ ë‚˜íŠ¸ë¥¨ì€ ë‚´ì«“ê³ , ë„ë§ê°”ë˜ í¬íƒ€ìŠ˜ì€ ë‹¤ì‹œ ì¡ì•„ë‹¤ê°€ ì§‘ì•ˆì— ì±„ì›Œ** ë„£ì–´. ê·¸ë˜ì•¼ë§Œ ë‹¤ìŒ ë°•ë™, ë‹¤ìŒ ì—°ê·¹ì„ ë‹¤ì‹œ ì‹œì‘í•  ìˆ˜ ìˆê±°ë“ . ì´ê²Œ ë°”ë¡œ ìš°ë¦¬ê°€ ì‚´ì•„ìˆëŠ” ë§¤ ìˆœê°„ ë°˜ë³µë˜ëŠ” ê¸°ì  ê°™ì€ ìŠ¤í† ë¦¬ì•¼.\n![image.png](Cardio/image%203.png)\n- **Class I Antiarrhythmics:**Â $Na^+$ê°€ ë“¤ì–´ì˜¤ëŠ” ë¬¸ì„ ì‚´ì§ ì ê°€ì„œ ì‹¬ì¥ ë°•ë™ì„ ëŠ¦ì¶¤.\n- **Class III Antiarrhythmics (Amiodarone):**Â K+Â ê°€ì¶œ(Phase 3)ì„ ëŠ¦ì¶°ì„œ ì „ì²´ ì‚¬ì´í´ì„ ê¸¸ê²Œ ëŠ˜ë¦¼.\n- **Calcium Channel Blockers (Verapamil):**Â $Ca^{2+}$ê°€ ë“¤ì–´ì˜¤ëŠ” ê±¸ ë§‰ì•„ ì‹¬ì¥ ìˆ˜ì¶•ë ¥ê³¼ í˜ˆì••ì„ ë‚®ì¶¤.\n---\nHeyde syndrome\n### 1. ì„¸ ì¤„ ìš”ì•½ (3-Line Summary)\n- **AS (Aortic Stenosis):** ì¢ì•„ì§„ ëŒ€ë™ë§¥íŒë§‰ì´ **'ë¶„ì‡„ê¸°'** ì—­í• ì„ í•¨. âš™ï¸\n- **vWF (von Willebrand Factor):** íŒë§‰ì„ ì§€ë‚˜ë‹¤ê°€ ê°ˆê¸°ê°ˆê¸° ì°¢ê²¨ì„œ ê¸°ëŠ¥ì„ ìƒìŒ (Acquired vWD).\n- **GI Bleed:** í˜ˆì•¡ì˜ 'ì ‘ì°©ì œ'ê°€ ì—†ìœ¼ë‹ˆ ëŒ€ì¥ì˜ **Angiodysplasia(í˜ˆê´€í˜•ì„±ì´ìƒ)**ì—ì„œ í”¼ê°€ í‘í‘! ğŸ©¸\n![image.png](Cardio/image%204.png)\n![image.png](Cardio/image%205.png)\n![image.png](Cardio/image%206.png)","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-21","focus_area":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"# LM_pulmo\n# Physiology\n---\n## 2. The Ventilator Framework: A Mental Model ğŸ§ \nICUì˜ ì¸ê³µí˜¸í¡ê¸°(Ventilator)ëŠ” ë³µì¡í•´ ë³´ì´ì§€ë§Œ, ë³¸ì§ˆì ìœ¼ë¡œ **ë‘ ê°€ì§€** ë³„ê°œì˜ ë¬¸ì œë¥¼ ê´€ë¦¬í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n| **ê¸°ëŠ¥** | **ëª©í‘œ** | **ì¡°ì ˆ ë ˆë²„ (Controls)** |\n| --- | --- | --- |\n| **Oxygenation (ì‚°ì†Œí™”)** | í˜ˆì•¡ì— ì‚°ì†Œ ê³µê¸‰ (Raise PO2) | **FiO2** (ì‚°ì†Œ ë†ë„), **PEEP** (í˜¸ê¸°ë§ ì–‘ì••) |\n| **Ventilation (í™˜ê¸°)** | ì´ì‚°í™”íƒ„ì†Œ ë°°ì¶œ (Remove CO2) | **Respiratory Rate** (RR), **Tidal Volume** (TV) |\n### A. Oxygenation Controls (ì‚°ì†Œí™” ì¡°ì ˆ) ğŸ”´\n1. **FiO2 (Fraction of Inspired Oxygen)**: í¡ì… ì‚°ì†Œ ë†ë„. (ëŒ€ê¸° 21% ~ 100%)\n2. **PEEP (Positive End-Expiratory Pressure)**: í˜¸í¡ ëì— íí¬ê°€ ìª¼ê·¸ë¼ë“¤ì§€ ì•Šê²Œ ì¡ì•„ì£¼ëŠ” ì••ë ¥.\n    - *Rule*: SpO2ê°€ ë‚®ìœ¼ë©´(ì €ì‚°ì†Œì¦), **FiO2**ë¥¼ ì˜¬ë¦¬ê±°ë‚˜ **PEEP**ì„ ì˜¬ë¦½ë‹ˆë‹¤.\n    - â˜… **Safety Rule**: 100% ì‚°ì†Œë¥¼ ì˜¤ë˜ ì“°ë©´ **Oxygen Toxicity** (Free radical ì†ìƒ)ê°€ ë°œìƒí•©ë‹ˆë‹¤. ëª©í‘œëŠ” FiO2ë¥¼ 60% ë¯¸ë§Œìœ¼ë¡œ ë‚®ì¶”ëŠ” ê²ƒì…ë‹ˆë‹¤. ì´ë¥¼ ìœ„í•´ **PEEPì„ ë†’ì—¬ì„œ** íí¬ë¥¼ ì—´ì–´ë‘ê³  ì‚°ì†Œ ë†ë„ëŠ” ì¤„ì´ëŠ” ì „ëµì„ ì”ë‹ˆë‹¤.\n### B. Ventilation Controls (í™˜ê¸° ì¡°ì ˆ) ğŸ”µ\n1. **Respiratory Rate (RR)**: í˜¸í¡ìˆ˜.\n2. **Tidal Volume (TV)**: 1íšŒ í™˜ê¸°ëŸ‰.\n    - *Rule*: CO2ê°€ ë†’ìœ¼ë©´(ì‚°ì¦), **RR**ì„ ë†’ì´ê±°ë‚˜ **TV**ë¥¼ í‚¤ì›Œì„œ CO2ë¥¼ ì”»ì–´ëƒ…ë‹ˆë‹¤ (Blow off).\n    - **Minute Ventilation (ë¶„ë‹¹ í™˜ê¸°ëŸ‰)** = RR Ã— TV. ë‘˜ ì¤‘ í•˜ë‚˜ë¥¼ ì˜¬ë¦¬ë©´ ë¨.\n    - â˜… **Safety Rule**: **Tidal Volumeì€ Ideal Body Weight (IBW) ê¸°ì¤€ 6-8 mL/kg**ë¡œ ì„¤ì •í•´ì•¼ í•©ë‹ˆë‹¤. (ì‹¤ì œ ì²´ì¤‘ ì•„ë‹˜! 150kg í™˜ìë„ í‚¤ê°€ ì‘ìœ¼ë©´ í ìš©ì ì€ ì‘ìŒ). ê³¼ë„í•œ TVëŠ” íë¥¼ í„°ëœ¨ë¦´ ìˆ˜ ìˆìŒ (**Barotrauma/Volutrauma**).\n---\n## 3. ARDS Strategy: \"Baby Lung\" Concept ğŸ‘¶ğŸ«\n**ARDS (Acute Respiratory Distress Syndrome)** í™˜ìì˜ íëŠ” ë”±ë”±í•˜ê³  ë¬´ê²ê³  ì –ì–´ ìˆìŠµë‹ˆë‹¤(Stiff, wet, heavy). ê¸°ëŠ¥í•˜ëŠ” í ìš©ì ì€ ì•„ì£¼ ì‘ìŠµë‹ˆë‹¤ (Baby lung).\n- **Lung Protective Ventilation (í ë³´í˜¸ í™˜ê¸°)** ì „ëµ:\n    1. **Low Tidal Volume**: ì‘ì€ íì— ë§ì¶° TVë¥¼ ë‚®ê²Œ ì„¤ì • (**4-6 mL/kg**ê¹Œì§€ ì¤„ì„).\n    2. **High PEEP**: ì –ì€ íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ëŠ” ê²ƒì„ ë§‰ê¸° ìœ„í•´ PEEPì„ ë†’ê²Œ ì„¤ì • (> 10 cmH2O).\n    3. **Permissive Hypercapnia**: TVë¥¼ ì¤„ì˜€ìœ¼ë‹ˆ CO2ê°€ ì¢€ ìŒ“ì—¬ë„(pH > 7.25) ìš©ì¸í•©ë‹ˆë‹¤. íë¥¼ í„°ëœ¨ë¦¬ëŠ” ê²ƒë³´ë‹¤ ë‚˜ìŒ.\n    4. **Prone Positioning (ì—ë“œë¦° ìì„¸)**: ë“± ìª½ í(Dorsal lung)ë¥¼ í´ì„œ ì‚°ì†Œí™”ë¥¼ ê°œì„ í•˜ê³  ì‚¬ë§ë¥ ì„ ë‚®ì¶¤. (â˜… **Mortality Benefit** ìˆìŒ!)\n---\n## 4. The Pressure Puzzle: PIP vs. Plateau ğŸ§©\në²¤í‹¸ë ˆì´í„° ì•ŒëŒì´ \"High Pressure!\"ë¼ê³  ìš¸ë¦´ ë•Œ, ë‘ ê°€ì§€ ìˆ«ìë¥¼ í™•ì¸í•˜ë©´ ì§„ë‹¨ì´ ëë‚©ë‹ˆë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-1","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","mnemonic"]}
